Circulating Fibroblast Growth Factor-21 Is Elevated in Impaired Glucose Tolerance and Type 2 Diabetes and Correlates With Muscle and Hepatic Insulin Resistance

Cited by (390)

Items 101–200 of 390

1. Cardiac actions of fibroblast growth factor 23
   Christian Faul · 2016 · Bone
2. Metabolic role of fibroblast growth factor 21 in liver, adipose and nervous system tissues
   Xiaolong Lin, Yuan Bo Liu, Huijun Hu · 2017 · Biomedical Reports
3. Identification of biomarkers for physical frailty and sarcopenia through a new multi-marker approach: results from the BIOSPHERE study
   Riccardo Calvani, Anna Picca, Federico Marini, Alessandra Biancolillo, Jacopo Gervasoni, Silvia Persichilli, Aniello Primiano, Hélio José Coelho‐Júnior, Matteo Cesari, Maurizio Bossola et al. · 2020 · GeroScience
4. Insulin resistance is associated with Fibroblast Growth Factor-23 in stage 3–5 chronic kidney disease patients
   Jocelyn S. Garland, Rachel Mary Holden, Robert Ross, Michael A. Adams, Robert L. Nolan, Wilma M. Hopman, Alexander Ross Morton · 2013 · Journal of Diabetes and its Complications
5. Fibroblast growth factors in control of lipid metabolism: from biological function to clinical application
   Dicky Struik, Marleen B. Dommerholt, Johan W. Jonker · 2019 · Current Opinion in Lipidology
6. Serum FGF21 levels are increased in newly diagnosed type 2 diabetes with nonalcoholic fatty liver disease and associated with hsCRP levels independently
   Xuesong Li, Xiaofang Fan, Fengdong Ren, Yu Zhang, Chunfang Shen, Guoguang Ren, Jue Sun, Ning Zhang, Weiqing Wang, Guang Ning et al. · 2011 · Diabetes Research and Clinical Practice
7. Daily physical activity, fasting glucose, uric acid, and body mass index are independent factors associated with serum fibroblast growth factor 21 levels
   Cuevas-Ramos, Daniel, Almeda-Valdes, Paloma, Gómez-Pérez, Francisco J, Meza-Arana, Clara Elena, Cruz-Bautista, Ivette, Arellano-Campos, Olimpia, Navarrete-López, Mariana, Aguilar-Salinas, Carlos A · 2010 · European Journal of Endocrinology
8. The role of fibroblast growth factor 21 in diabetes and its complications: A review from clinical perspective
   Jianjun Liu, Joo Pin Foo, Sylvia Liu, Su Chi Lim · 2015 · Diabetes Research and Clinical Practice
9. Fibroblast Growth Factor 21 Protects Against High Glucose Induced Cellular Damage and Dysfunction of Endothelial Nitric-Oxide Synthase in Endothelial Cells
   Xiaomei Wang, Shuang‐Shuang Song, Hang Xiao, Pan Gao, Xue-Jun Li, Liangyi Si · 2014 · Cellular Physiology and Biochemistry
10. Relation between fibroblast growth factor–21, adiposity, metabolism, and weight reduction
    Knut Mai, Franziska Schwarz, Thomas Bobbert, Janin Andres, Anke Aßmann, Andreas F. H. Pfeiffer, Joachim Spranger · 2010 · Metabolism
11. Dynamic Change of Serum FGF21 Levels in Response to Glucose Challenge in Human
    Zhuofeng Lin, Qi Gong, Chaoming Wu, Jiawen Yu, Tingting Lü, Xuebo Pan, Shaoqiang Lin, Xiaokun Li · 2012 · The Journal of Clinical Endocrinology & Metabolism
12. Diet polyphenol curcumin stimulates hepatic Fgf21 production and restores its sensitivity in high fat diet fed male mice
    Kejing Zeng, Lili Tian, Rucha Patel, Weijuan Shao, Zhuolun Song, Ling Liu, Justin Manuel, Xue‐Zhong Ma, Ian D. McGilvray, Carolyn L. Cummins et al. · 2016 · Endocrinology
13. Association between serum fibroblast growth factor 21 and diabetic nephropathy
    Weixia Jian, Wenhui Peng, Jie Jin, Xueru Chen, Wenjun Fang, Weixing Wang, Qin Li, Yan Dong, Qing Su · 2011 · Metabolism
14. A low-protein diet induces body weight loss and browning of subcutaneous white adipose tissue through enhanced expression of hepatic fibroblast growth factor 21 (FGF21)
    Pérez‐Martí, Albert, Garcia‐Guasch, Maite, Tresserra‐Rimbau, Anna, Carrilho‐Do‐Rosário, Alexandra, Estruch, Ramon, Salas‐Salvadó, Jordi, Martínez‐González, Miguel Ángel, Lamuela‐Raventós, Rosa, Marrero, Pedro F., Haro, Diego et al. · 2017 · Molecular Nutrition & Food Research
15. Research Perspectives on the Regulation and Physiological Functions of FGF21 and its Association with NAFLD
    Takeshi Inagaki · 2015 · Frontiers in Endocrinology
16. Activation of cardiac AMPK-FGF21 feed-forward loop in acute myocardial infarction: Role of adrenergic overdrive and lipolysis byproducts
    Hiroaki Sunaga, Norimichi Koitabashi, Tatsuya Iso, Hiroki Matsui, Masaru Obokata, Ryo Kawakami, Masami Murakami, Tomoyuki Yokoyama, Masahiko Kurabayashi · 2019 · Scientific Reports
17. Role of exercise-induced hepatokines in metabolic disorders
    Ennequin, Gaël, Sirvent, Pascal, Whitham, Martin · 2019 · American Journal of Physiology-Endocrinology and Metabolism
18. Serum FGF21 increases with hepatic fat accumulation in pediatric onset intestinal failure
    Annika Mutanen, Päivi Heikkilä, Jouko Lohi, Taneli Raivio, Hannu Jalanko, Mikko P. Pakarinen · 2013 · Journal of Hepatology
19. Alterations in 3-Hydroxyisobutyrate and FGF21 Metabolism Are Associated With Protein Ingestion–Induced Insulin Resistance
    Lydia-Ann L.S. Harris, Gordon Ian Smith, Bruce W. Patterson, Raja Siva Ramaswamy, Adewole L. Okunade, Shannon C. Kelly, Lane C. Porter, Samuel Klein, Jun Yoshino, Bettina Mittendorfer · 2017 · Diabetes
20. Serum FGF21 levels are elevated in association with lipodystrophy, insulin resistance and biomarkers of liver injury in HIV-1-infected patients
    Peré Domingo, José Miguel Gallego-Escuredo, Joan Carles Domingo, María del Mar Gutiérrez, Gracia María Mateo, Irene Fernández, Francesc Vidal, Marta Giralt, Francesc Villarroya · 2010 · AIDS
21. FGF21 Takes a Fat Bite
    Carles Cantó, Johan H. Auwerx · 2012 · Science
22. Serum fibroblast growth factor 21 levels is associated with lower extremity atherosclerotic disease in Chinese female diabetic patients
    Xiaoyan Zhang, Yanyun Hu, Hui Zeng, Lianxi Li, Jungong Zhao, Jun Zhao, Fang Liu, Yuqian Bao, Weiping Jia · 2015 · Cardiovascular Diabetology
23. Intact regulation of muscle expression and circulating levels of myokines in response to exercise in patients with type 2 diabetes
    Rugivan Sabaratnam, Andreas James Thestrup Pedersen, Jonas M. Kristensen, Aase Handberg, Jørgen F. P. Wojtaszewski, Kurt Højlund · 2018 · Physiological Reports
24. Attenuated fibroblast growth factor 21 response to acute aerobic exercise in obese individuals
    Slusher, A.L., Whitehurst, M., Zoeller, R.F., Mock, J.T., Maharaj, M., Huang, C.-J. · 2015 · Nutrition Metabolism and Cardiovascular Diseases
25. The regulation of FGF21 gene expression by metabolic factors and nutrients
    Anjeza Erickson, Régis F. Moreau · 2016 · Hormone Molecular Biology and Clinical Investigation
26. Revealing the role of peroxisome proliferator-activated receptor β/δ in nonalcoholic fatty liver disease
    Mohammad Zarei, David Aguilar-Recarte, Xavier Palomer, Manuel Vázquez‐Carrera · 2020 · Metabolism
27. Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection—Liver: The “Musketeer” in the Spotlight
    Stefano Ballestri, Fabio Nascimbeni, Dante Romagnoli, Enrica Baldelli, Giovanni Targher, Amedeo Lonardo · 2016 · International Journal of Molecular Sciences
28. Effect of exercise intensity on circulating hepatokine concentrations in healthy men
    Scott A. Willis, Jack Alistair Sargeant, Alice Emily Thackray, Thomas E. Yates, David J. Stensel, Guruprasad Padur Aithal, James A. King · 2019 · Applied Physiology, Nutrition, and Metabolism
29. Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism
    Tae Hyun Kim, Dong-Gyun Hong, Yoon Mee Yang · 2021 · Biomedicines
30. Prospect of Sodium–Glucose Co-transporter 2 Inhibitors Combined With Insulin for the Treatment of Type 2 Diabetes
    Yinqiu Yang, Chenhe Zhao, Yangli Ye, Mingxiang Yu, Xinhua Qu · 2020 · Frontiers in Endocrinology
31. Organokines in disease
    2020 · Advances in clinical chemistry
32. The Regulatory Role of the Central and Peripheral Serotonin Network on Feeding Signals in Metabolic Diseases
    Katsunori Nonogaki · 2022 · International Journal of Molecular Sciences
33. Metabolic actions of fibroblast growth factor 21
    Daniel Cuevas Ramos, Carlos Alberto Aguilar-Salinas, Francisco Javier Gomez-Perez · 2012 · Current Opinion in Pediatrics
34. Characterization and comparison of sodium-glucose cotransporter 2 inhibitors: Part 2. Antidiabetic effects in type 2 diabetic mice
    Atsuo Tahara, Toshiyuki Takasu, Masanori Yokono, Masakazu Imamura, Eiji Kurosaki · 2016 · Journal of Pharmacological Sciences
35. Bitter melon extract attenuating hepatic steatosis may be mediated by FGF21 and AMPK/Sirt1 signaling in mice
    Yongmei Yu, Xian H. Zhang, Blake Ebersole, David Ribnicky, Zhong Q. Wang · 2013 · Scientific Reports
36. Serum fibroblast growth factor 21 is predictive of combined cardiovascular morbidity and mortality in patients with type 2 diabetes at a relatively short-term follow-up
    Monika Lenart-Lipińska, Beata Matyjaszek‐Matuszek, Wojciech Gernand, Andrzej Marcin Nowakowski, Janusz Solski · 2013 · Diabetes Research and Clinical Practice
37. Hepatic insulin resistance and increased hepatic glucose production in mice lacking Fgf21
    João Paulo Camporez, Mohamed Asrih, Dongyan Zhang, Mario Kahn, Varman T. Samuel, Michael J. Jurczak, François R. Jornayvaz · 2015 · Journal of Endocrinology
38. Role of Circulating Fibroblast Growth Factor 21 Measurement in Primary Prevention of Coronary Heart Disease Among Chinese Patients With Type 2 Diabetes Mellitus
    Chi‐Ho Lee, Yu Cho Woo, Wing Sun Chow, Chloe Y. Y. Cheung, Carol Ho Yi Fong, Michele Mae Ann Yuen, Aimin Xu, Hung‐Fat Tse, Karen S.L. Lam · 2017 · Journal of the American Heart Association
39. Effects of aerobic exercise on fibroblast growth factor 21 in overweight and obesity. A systematic review
    María Porflitt-Rodríguez, Valentina Guzmán-Arriagada, Romina Sandoval-Valderrama, Charmaine S. Tam, Francisca Pavicic, Pamela Ehrenfeld, Sergio Martínez-Huenchullán · 2022 · Metabolism
40. Implications of Fibroblast growth factor/Klotho system in glucose metabolism and diabetes
    Javier Donate‐Correa, Ernesto Martín‐Núñez, Nayra Pérez‐Delgado, Mercedes Muros de Fuentes, Alberto Ortíz, Carmen Mora Fernández, Juan F. Navarro‐González · 2015 · Cytokine & Growth Factor Reviews
41. Heme-Regulated eIF2α Kinase Modulates Hepatic FGF21 and Is Activated by PPARβ/δ Deficiency
    Mohammad Zarei, Emma Barroso, Rosana Leiva, Marta Barniol‐Xicota, Eugènia Pujol, Carmen Escolano, Santiago Vázquez, Xavier Palomer, Virginia Pardo, Águeda González‐Rodríguez et al. · 2016 · Diabetes
42. Levels of metabolic markers in drug-naive prediabetic and type 2 diabetic patients
    Amal A. Akour, Violet N. Kasabri, Nailya Bulatova, Yasser Khalil Bustanji, Randa G. Naffa, Dana Hyassat, Nahla M. Khawaja, Haidar Bustanji, Ayman A. Zayed, Munther S. Momani · 2016 · Acta Diabetologica
43. Curcumin and dietary polyphenol research: beyond drug discovery
    Tianru Jin · 2018 · Acta Pharmacologica Sinica
44. Recruitment of Histone Methyltransferase G9a Mediates Transcriptional Repression of Fgf21 Gene by E4BP4 Protein*
    Xin Tong, Deqiang Zhang, Katie L. Buelow, Anirvan Guha, Blake Arthurs, Hugh J.M. Brady, Lei Yin · 2013 · Journal of Biological Chemistry
45. Fibroblast growth factor 21 in chronic kidney disease
    Sahapab Anuwatmatee, Shudi Tang, Ben J. Wu, Kerry‐Anne Rye, Kwok Leung Ong · 2017 · Clinica Chimica Acta
46. Decrease in circulating fibroblast growth factor 21 after an oral fat load is related to postprandial triglyceride-rich lipoproteins and liver fat
    Niina Matikainen, Marja‐Riitta Taskinen, Sanna Stennabb, Nina M I Lundbom, Antti Hakkarainen, Kirsi Vaaralahti, Taneli Raivio · 2011 · European Journal of Endocrinology
47. Effects of dapagliflozin on the serum levels of fibroblast growth factor 21 and myokines and muscle mass in Japanese patients with type 2 diabetes: A randomized, controlled trial
    Hajime Yamakage, Masashi Tanaka, Takayuki Inoue, Shinji Odori, Toru Kusakabe, Noriko Satoh‐Asahara · 2019 · Journal of Diabetes Investigation
48. FGF21 and Chronic Kidney Disease.
    J. Salgado, M. A. Goes, N. Salgado · 2021 · Metabolism: Clinical and Experimental
49. Sulforaphane Regulates Glucose and Lipid Metabolisms in Obese Mice by Restraining JNK and Activating Insulin and FGF21 Signal Pathways
    Shuhua Tian, Yunfan Wang, Xiangfei Li, Jie Liu, Jing Wang, Yingjian Lu · 2021 · Journal of Agricultural and Food Chemistry
50. Combined genetic deletion of GDF15 and FGF21 has modest effects on body weight, hepatic steatosis and insulin resistance in high fat fed mice
    Satish Patel, Afreen Haider, Anna Álvarez-Guaita, Guillaume Bidault, Julia S. El-Sayed Moustafa, Esther Guiu‐Jurado, John A. Tadross, James Warner, James Harrison, Sam Virtue et al. · 2022 · Molecular Metabolism
51. Non-pharmacological management options for MAFLD: a practical guide
    José Tadeu Stefano, Sebastião Mauro Bezerra Duarte, Renato Gama Altikes, Claudia Pinto Marques Souza de Oliveira · 2023 · Therapeutic Advances in Endocrinology and Metabolism
52. FGF21 (Fibroblast Growth Factor 21) Defines a Potential Cardiohepatic Signaling Circuit in End-Stage Heart Failure
    Salah Sommakia, Naredos H. Almaw, Sandra H. Lee, Dinesh K. A. Ramadurai, Iosif Taleb, Christos P. Kyriakopoulos, Chris Stubben, Ling Jing, Robert A. Campbell, Rami A. Alharethi et al. · 2021 · Circulation Heart Failure
53. Artesunate treats obesity in male mice and non-human primates through GDF15/GFRAL signalling axis
    Xuanming Guo, Pallavi Asthana, Lixiang Zhai, Ka Wing Cheng, Susma Gurung, Jiangang Huang, Jiayan Wu, Yijing Zhang, Arun Kumar Mahato, Märt Saarma et al. · 2024 · Nature Communications
54. Novel Mediators of Adipose Tissue and Muscle Crosstalk
    Ira Indrakusuma, Henrike Sell, Jürgen Eckel · 2015 · Current Obesity Reports
55. The Role and Potential Therapeutic Implications of the Fibroblast Growth Factors in Energy Balance and Type 2 Diabetes
    Maitane Izaguirre, Marı́a J. Gil, Ignacío Monreal, Fabrizio Montecucco, Gema Frühbeck, Victoria Catalán · 2017 · Current Diabetes Reports
56. The potential effect of metformin on fibroblast growth factor 21 in type 2 diabetes mellitus (T2DM)
    Hayder Mutter Al-Kuraishy, Ali Ismail Al-Gareeb, ‏Hebatallah M. Saad, Gaber El‐Saber Batiha · 2023 · Inflammopharmacology
57. Manipulation of Dietary Amino Acids Prevents and Reverses Obesity in Mice Through Multiple Mechanisms That Modulate Energy Homeostasis
    Chiara Ruocco, Maurizio Ragni, Fabio Rossi, Pierluigi Carullo, Veronica Ghini, Fabiana Piscitelli, Adele Cutignano, Emiliano Manzo, Rafael M. Ioris, Franck Bontems et al. · 2020 · Diabetes
58. Fibroblast growth factor 21 expressions in white blood cells and sera of patients with gestational diabetes mellitus during gestation and postpartum
    Siming Li, Wenfei Wang, Lihong Zhou, Lei Ma, Ying An, Wen-juan Xu, Tian-He Li, Yin-Hang Yu, Deshan Li, Yàn Liú · 2014 · Endocrine
59. Serum fibroblast growth factor 21 levels are increased in atrial fibrillation patients
    Xinyuan Han, Chunyan Chen, Gong Cheng, Cui Xie, Meng Yang, Xiling Shou, Chaofeng Sun · 2015 · Cytokine
60. Plasma fibroblast growth factor 21 levels increase with ectopic fat accumulation and its receptor levels are decreased in the visceral fat of patients with type 2 diabetes
    Eun Shil Hong, Cheong Lim, Hye Yeon Choi, Yun Kyung Lee, Eu Jeong Ku, Jae Hoon Moon, Kyong Soo Park, Hak Chul Jang, Sung Hee Choi · 2019 · BMJ Open Diabetes Research & Care
61. Hepatokines as a Molecular Transducer of Exercise
    Dae Yun Seo, Se-Hwan Park, Jubert C. Marquez, Hyo‐Bum Kwak, Tae Nyun Kim, Jun Hyun Bae, Jin‐Ho Koh, Jin Han · 2021 · Journal of Clinical Medicine
62. Significant gender difference in serum levels of fibroblast growth factor 21 in Danish children and adolescents
    Amalie Bisgaard, Kaspar Sørensen, Trine Holm Johannsen, Jørn Wulff Helge, Anna‐Maria Andersson, Anders Juul · 2014 · International Journal of Pediatric Endocrinology
63. Protein Appetite at the Interface between Nutrient Sensing and Physiological Homeostasis
    Md Shahjalal Hossain Khan, Redin A. Spann, Heike Münzberg, Sangho Yu, Vance L. Albaugh, Yanlin He, Hans‐Rudolf Berthoud, Christopher D. Morrison · 2021 · Nutrients
64. Modulation of energy balance by fibroblast growth factor 21
    Daniel Cuevas Ramos, Carlos Alberto Aguilar-Salinas · 2016 · Hormone Molecular Biology and Clinical Investigation
65. Molecular mechanism and therapeutic significance of essential amino acids in metabolically associated fatty liver disease
    Yuting Deng, Mengsi Hu, Shufang Huang, Nian Fu · 2024 · The Journal of Nutritional Biochemistry
66. Expression of Fibroblast Growth Factor-21 in Muscle Is Associated with Lipodystrophy, Insulin Resistance and Lipid Disturbances in Patients with HIV
    Birgitte Lindegaard, Thine Hvid, Thomas Sahl Grøndahl, Christian Frøsig, Jan Gerstoft, Pernille Højman, Bente Klarlund Pedersen · 2013 · PLoS ONE
67. Circulating Fibroblast Growth Factor 21 (Fgf21) as Diagnostic and Prognostic Biomarker in Renal Cancer
    María Elena Knott, José Nicolas Minatta · 2016 · Journal of Molecular Biomarkers & Diagnosis
68. Cobalt chloride decreases fibroblast growth factor-21 expression dependent on oxidative stress but not hypoxia-inducible factor in Caco-2 cells
    Yanlong Liu, Chunhong Wang, Yuhua Wang, Zhenhua Ma, Jian Xiao, Craig James McClain, Xiaokun Li, Wenke Feng · 2012 · Toxicology and Applied Pharmacology
69. Fibroblast Growth Factor 21 Stimulates Pancreatic Islet Autophagy via Inhibition of AMPK-mTOR Signaling
    Sam Tsz Wai Cheng, Stephen Yu Ting Li, Po Sing Leung · 2019 · International Journal of Molecular Sciences
70. Fibroblast growth factor 1 levels are elevated in newly diagnosed type 2 diabetes compared to normal glucose tolerance controls
    Su Wang, Qichao Yang, Shuqin Yu, Ruirong Pan, Dan Jiang, Yuanxin Liu, Hao Hu, Wenjun Sun, Xiafei Hong, Haoying Xue et al. · 2016 · Endocrine Journal
71. Circulating FGF19 and FGF21 surge in early infancy from infra- to supra-adult concentrations
    David Sánchez‐Infantes, José Miguel Gallego-Escuredo, Marta Díaz, Gemma Aragonès, Giorgia Sebastiani, Abel López‐Bermejo, Francis de Zegher, Peré Domingo, Francesc Villarroya, Lourdes Ibáñez · 2015 · International Journal of Obesity
72. The role of FGF21 in type 1 diabetes and its complications
    Jian Zhang, Wenya Weng, Kai Wang, Xuemian Lu, Lu Cai, Jian Sun · 2018 · International Journal of Biological Sciences
73. Prolonged Glucagon Infusion Does Not Affect Energy Expenditure in Individuals with Overweight/Obesity: A Randomized Trial
    Whytock, Katie L., Carnero, Elvis A., Vega, Rick B., Tillner, Joachim, Bock, Christopher, Chivukula, Karthik, Yi, Fanchao, Meyer, Christian, Smith, Steven R., Sparks, Lauren M. · 2021 · Obesity
74. Effects of Short-Term Continuous Subcutaneous Insulin Infusion on Fasting Plasma Fibroblast Growth Factor-21 Levels in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
    Mengliu Yang, Jing Dong, Hua Liu, Ling Li, Gangyi Yang · 2011 · PLoS ONE
75. Insulin Resistance and Insulin Handling in Chronic Kidney Disease
    Vishnu P. Parvathareddy, Jiao Wu, Sandhya S. Thomas · 2023 · Comprehensive physiology
76. Reduction in serum fibroblast growth factor-21 after gastric bypass is related to changes in hepatic fat content
    Karen Fjeldborg, Steen B. Pedersen, Holger Jon Møller, Bjørn Richelsen · 2017 · Surgery for Obesity and Related Diseases
77. Mistranslation Drives Alterations in Protein Levels and the Effects of a Synonymous Variant at the Fibroblast Growth Factor 21 Locus
    Ali Bayoumi, Asmaa Elsayed, Shuanglin Han, Salvatore Petta, Leon Anton Adams, R. Aller, Anis Khan, Carmelo García‐Monzón, M. Arias, Luca Miele et al. · 2021 · Advanced Science
78. The Speed of Ingestion of a Sugary Beverage Has an Effect on the Acute Metabolic Response to Fructose
    Mehmet Kanbay, Begüm Güler Şentürk, Lale A. Ertuğlu, Tuncay Dağel, Barış Afşar, Said İncir, Arzu Baygül, Adrian Constantin Covic, Ana Andrés-Hernando, Laura Gabriela Sánchez‐Lozada et al. · 2021 · Nutrients
79. Mechanisms and pharmacotherapy of hypertension associated with type 2 diabetes.
    V. Kamalumpundi, Elham Shams, Cally Tucker, Lin-xian Cheng, Joshua Peterson, S. Thangavel, Oloigbe Ofori, Marcelo Correia · 2022 · Biochemical Pharmacology
80. Albumin-fused long-acting FGF21 analogue for the treatment of non-alcoholic fatty liver disease
    Mayuko Chikamatsu, Hiroshi Watanabe, Yuhi Shintani, Ryota Murata, Masako Miyahisa, Ayano Nishinoiri, Tadashi Imafuku, Mei Takano, Nanaka Arimura, Koh‐ichi Yamada et al. · 2023 · Journal of Controlled Release
81. Fibroblast growth factor 21 as a biomarker for NAFLD: integrating pathobiology into clinical practice
    Morris-Stiff, Gareth, Feldstein, Ariel E. · 2010 · Journal of Hepatology
82. Improved FGF21 Sensitivity and Restored FGF21 Signaling Pathway in High-Fat Diet/Streptozotocin-Induced Diabetic Rats After Duodenal-Jejunal Bypass and Sleeve Gastrectomy
    Qiaoran Liu, Shuo Wang, Meng Wei, Xin Huang, Yugang Cheng, Yi Shao, Pingtian Xia, Mingwei Zhong, Shaozhuang Liu, Guangyong Zhang et al. · 2019 · Frontiers in Endocrinology
83. Moderate-Intensity Continuous Training Improves FGF21 and KLB Expression in Obese Mice
    Yingzhe Xiong, Yan Chen, Yao Liu, Bing Zhang · 2020 · Biochemistry (Moscow)
84. Cord blood FGF21 in gestational diabetes and its relationship with postnatal growth
    Ana Megía, Pilar Gil-Lluís, Sílvia Näf, Victòria Ceperuelo‐Mallafré, José Miguel González-Clemente, Gemma Llauradó, Catalina Núñez‐Roa, Kelly Roche, Mónica Ballesteros, Rosa Elena Yañez et al. · 2015 · Acta Diabetologica
85. Association between insulin resistance and impairment of FGF21 signal transduction in skeletal muscles
    Ja Young Jeon, Sung‐E Choi, Eun Suk Ha, Tae Ho Kim, Jong Gab Jung, Seung Jin Han, Hae Jin Kim, Dae Jung Kim, YUP Y. KANG, Kwan Woo Lee · 2016 · Endocrine
86. Translational Pharmacology and Physiology of Brown Adipose Tissue in Human Disease and Treatment
    Christopher J. Larson · 2018 · Handbook of experimental pharmacology
87. Relationship of fibroblast growth factor 21 with subclinical atherosclerosis and cardiovascular events: Multi-Ethnic Study of Atherosclerosis
    Kwok Leung Ong, Steven Campbell, Ben J. Wu, Robyn L. McClelland, John Kokkinos, Moysés Szklo, Joseph F. Polak, Matthew Allison, K.-A. Rye · 2019 · Atherosclerosis
88. FGF21-FGFR4 signaling in cardiac myocytes promotes concentric cardiac hypertrophy in mouse models of diabetes
    Christopher Yanucil, Dominik Kentrup, Xueyi Li, Alexander Grabner, Karla J. Schramm, Eliana Cecilia Martinez, Jinliang Li, Isaac D. Campos, Brian A. Czaya, Kylie Heitman et al. · 2022 · Scientific Reports
89. Serum fibroblast growth factor 21 in human obesity: regulation by insulin infusion and relationship with glucose and lipid oxidation
    Marek Strączkowski, Monika Karczewska‐Kupczewska, Agnieszka Adamska, Elżbieta Otziomek, Irina Kowalska, Agnieszka Nikołajuk · 2013 · International Journal of Obesity
90. Insulin Resistance and Insulin Handling in Chronic Kidney Disease
    Vishnu P. Parvathareddy, Jiao Wu, Sandhya S. Thomas · 2023 · Comprehensive physiology
91. Methionine restriction alleviates diabetes-associated cognitive impairment via activation of FGF21
    Yuyu Zhang, Yajie Wang, Yiju Li, Jingxi Pang, Annika Höhn, Weixuan Dong, Rui Hua Gao, Yan Liu, Da Wang, Yongbo She et al. · 2024 · Redox Biology
92. Biomarkers in metabolic syndrome
    Young Hye Cho, Youngin Lee, Jung In Choi, Sae Rom Lee, Sang Yeoup Lee · 2022 · Advances in clinical chemistry
93. Role of liver FGF21-KLB signaling in ketogenic diet-induced amelioration of hepatic steatosis
    Wanrong Guo, Huanyi Cao, Yunfeng Shen, Wuguo Li, Wei J. Wang, Lidan Cheng, Mengyin Cai, Fen Liang Xu · 2024 · Nutrition and Diabetes
94. Nutritional regulation of fibroblast growth factor 21: from macronutrients to bioactive dietary compounds
    Albert Pérez‐Martí, Viviana Sandoval, Pedro F. Marrero, Diego Haro, Joana Relat · 2016 · Hormone Molecular Biology and Clinical Investigation
95. Roux-en-Y gastric bypass surgery is effective in fibroblast growth factor-21 deficient mice
    Christopher D. Morrison, Hao Zheng, Michael B. Mumphrey, R. Leigh Townsend, Heike Münzberg, Jianping Ye, Hans‐Rudolf Berthoud · 2016 · Molecular Metabolism
96. Fasting decreases plasma FGF21 in obese subjects and the expression of FGF21 receptors in adipose tissue in both lean and obese subjects
    Eva B. Nygaard, Cathrine Ørskov, Thomas Almdal, Henrik Vestergaard, Birgitte Andersen · 2018 · Journal of Endocrinology
97. Endoplasmic reticulum stress induces up-regulation of hepatic β-Klotho expression through ATF4 signaling pathway
    Kun Dong, Huating Li, Mingliang Zhang, Shan Jiang, Shuqin Chen, Jian Zhou, Zhi Dai, Qichen Fang, Weiping Jia · 2015 · Biochemical and Biophysical Research Communications
98. New insights about the putative role of myokines in the context of cardiac rehabilitation and secondary cardiovascular prevention
    Domenico Di Raimondo, Giuseppe Miceli, Gaia Musiari, Musiari Tuttolomondo, Antonio Ventura Pinto · 2017 · Annals of Translational Medicine
99. C‐peptide is associated with NAFLD inflammatory and fibrotic progression in type 2 diabetes
    Ningjian Wang, Yuying Wang, Wen Zhang, Yi Chen, Xiaoman Chen, Chiyu Wang, Qing Li, Chi Chen, Boren Jiang, Yingli Lu · 2019 · Diabetes/Metabolism Research and Reviews
100. Liraglutide Decreases Liver Fat Content and Serum Fibroblast Growth Factor 21 Levels in Newly Diagnosed Overweight Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
     Xinyue Li, Xiaojuan Wu, Yumei Jia, Jing Fu, Lin Zhang, Tao Jiang, Jia Liu, Guang Wang · 2021 · Journal of Diabetes Research